Home » Repros Says FDA Seeks More Studies for Testosterone Drug
Repros Says FDA Seeks More Studies for Testosterone Drug
The FDA has requested additional study data for Repros Therapeutics’ testosterone replacement drug Androxal. The agency also requested that a safety study be extended.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May